📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial. (2020)

First Author: Hoffman JJ

Attributed to: Epidemiological and statistical research on health problems of low and middle-income countries: MRC Tropical Epidemiology Group (TEG) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2020-038066

PubMed Identifier: 32998924

Publication URI: http://europepmc.org/abstract/MED/32998924

Type: Journal Article/Review

Volume: 10

Parent Publication: BMJ open

Issue: 9

ISSN: 2044-6055